Report shows physicians are operating in a difficult financial and mental environment.
Physician burnout was a problem before COVID, and the pandemic only made it worse. From surges to battles over masking, physicians are facing a difficult mental environment post pandemic, and the financial situation isn’t much better, according to a report from J.P. Morgan on physician payment trends.
According to the report, 47% of physicians reported they are burned out, while 74% of health care executives felt burned out within the past six months.
Many health care organizations are operating with negative margins and need external funding to stay in business. The report states that 36% of providers operated at a loss due to surges from COVID outbreaks, 41% of providers relied on external funding to remain open, and 53% of hospitals were projected to have negative margins through 2022.
A big financial problem for all providers is the rising cost of labor. Expenses related to health care workers have increased significantly, and these expenses are projected to continue to increase in the years to come. Health care organizations often struggle with how to attract, train, and retrain staff for vital positions, both clinical and administrative. To fill these gaps, organizations are more likely to incentivize staff with monetary rewards to help close staffing gaps, while some hire more staff than necessary to combat high turnover rates, according to the report.
All of these trends are only adding to the financial burden that providers are facing. The report found that labor expenses per patient are up more than one-third from pre-pandemic levels, with 20% of providers hiring more staff than needed for vital roles that have a high turnover rate. In addition, 15% of providers increased overtime rates to help incentivize staff to work uncovered shifts, and 31% of providers spent more than budgeted or typical on training and hiring new staff.
Labor expenses are projected to increase by $86 billion, while non-labor expenses are projected to increase by $49 billion.
This article was published by our sister publication Medical Economics.
First patient dosed in RECONNECT trial of RE104 for postpartum depression
July 23rd 2024Reunion Neuroscience Inc. initiates phase 2 trial of RE104, a novel short-duration psychedelic treatment for postpartum depression, aiming to provide rapid and effective relief for affected mothers.
Read More
Perinatal depression linked to increased midlife cardiovascular disease risk
June 26th 2024A recent study revealed a 36% increased risk of cardiovascular disease among women with perinatal depression, highlighting the need for incorporating reproductive health assessment into cardiovascular health evaluations.
Read More
Maternal distress during COVID-19 linked to reduced neonatal brain volumes
June 20th 2024A recent study found that maternal psychological distress during the COVID-19 pandemic is associated with reduced white matter and other brain volumes in newborns, highlighting potential long-term impacts on child development.
Read More